Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
March 21, 2026GesundheitsRecht

§ 33a Abs. 5 SGB V – Das Zuweisungs- und Kooperationsverbot bei digitalen Gesundheitsanwendungen im Spannungsfeld verfassungsrechtlicher Bestimmtheitsanforderungen

View Full Paper
Ask AI
Bookmark
Share

Authors

SRSebastian RetterMSMarina Schulte

Discussion

Loading...

Member takes

Overview

Der Beitrag analysiert das Zuweisungs- und Kooperationsverbot in digitalen Gesundheitsanwendungen, was rechtliche Unsicherheiten aufzeigt.

Key Points

  • The paper explores the restrictions posed by the Zuweisungs- und Kooperationsverbot regarding digital health applications.
  • Analysis of the legal structure of § 33a Abs. 5 SGB V.
  • Comparison with related regulations (§§ 31 MBO-Ä, 128 Abs. 2 SGB V, 11 ApoG).
  • Examination of constitutional requirements based on Article 20 Abs. 3 GG and Article 12 Abs. 1 GG.
  • The current regulation does not meet constitutional clarity requirements.
  • There is ambiguity in distinguishing between permissible and impermissible assignments.
  • Unclear terms like 'legal transactions' and 'agreements' create legal uncertainties.
  • Recommendations for precise interpretation of the target group and necessary reforms are proposed.

Cite This Study

Retter et al. (2026) studied this question.

synapsesocial.com/papers/69be35836e48c4981c673cb0https://doi.org/10.9785/gesr-2026-250304
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Problems and Barriers Regarding the Admission, Financing, and Service Provision of Digital Health Apps: Qualitative Stakeholder Survey2026 · 1 citations
  2. 2Healthcare effects and evidence robustness of reimbursable digital health applications in Germany: a systematic review2025 · 13 citations
  3. 3Digital Health Applications (DiGAs) on a Fast Track: Insights From a Data-Driven Analysis of Prescribable Digital Therapeutics in Germany From 2020 to Mid-20242024 · 19 citations
  4. 4Digital Health Applications (DiGAs) on a Fast Track: Insights From a Data-Driven Analysis of Prescribable Digital Therapeutics in Germany From 2020 to Mid-2024 (Preprint)2024
  5. 5Information regarding mHealth Apps in German Outpatient Mental Health Care: An Interview Study (Preprint)2025